Luna-Gutiérrez, M.; Ocampo-GarcÃa, B.; Jiménez-Mancilla, N.; Ancira-Cortez, A.; Trujillo-BenÃtez, D.; Hernández-Jiménez, T.; RamÃrez-Nava, G.; Hernández-RamÃrez, R.; Santos-Cuevas, C.; Ferro-Flores, G.
Targeted Endoradiotherapy with Lu2O3-iPSMA/-iFAP Nanoparticles Activated by Neutron Irradiation: Preclinical Evaluation and First Patient Image. Pharmaceutics 2022, 14, 720.
https://doi.org/10.3390/pharmaceutics14040720
AMA Style
Luna-Gutiérrez M, Ocampo-GarcÃa B, Jiménez-Mancilla N, Ancira-Cortez A, Trujillo-BenÃtez D, Hernández-Jiménez T, RamÃrez-Nava G, Hernández-RamÃrez R, Santos-Cuevas C, Ferro-Flores G.
Targeted Endoradiotherapy with Lu2O3-iPSMA/-iFAP Nanoparticles Activated by Neutron Irradiation: Preclinical Evaluation and First Patient Image. Pharmaceutics. 2022; 14(4):720.
https://doi.org/10.3390/pharmaceutics14040720
Chicago/Turabian Style
Luna-Gutiérrez, Myrna, Blanca Ocampo-GarcÃa, Nallely Jiménez-Mancilla, Alejandra Ancira-Cortez, Diana Trujillo-BenÃtez, Tania Hernández-Jiménez, Gerardo RamÃrez-Nava, Rodrigo Hernández-RamÃrez, Clara Santos-Cuevas, and Guillermina Ferro-Flores.
2022. "Targeted Endoradiotherapy with Lu2O3-iPSMA/-iFAP Nanoparticles Activated by Neutron Irradiation: Preclinical Evaluation and First Patient Image" Pharmaceutics 14, no. 4: 720.
https://doi.org/10.3390/pharmaceutics14040720
APA Style
Luna-Gutiérrez, M., Ocampo-GarcÃa, B., Jiménez-Mancilla, N., Ancira-Cortez, A., Trujillo-BenÃtez, D., Hernández-Jiménez, T., RamÃrez-Nava, G., Hernández-RamÃrez, R., Santos-Cuevas, C., & Ferro-Flores, G.
(2022). Targeted Endoradiotherapy with Lu2O3-iPSMA/-iFAP Nanoparticles Activated by Neutron Irradiation: Preclinical Evaluation and First Patient Image. Pharmaceutics, 14(4), 720.
https://doi.org/10.3390/pharmaceutics14040720
